Achieve End-to-End Supply Chain Visibility and Collaboration with TraceLink

Volatile demand fluctuations and an onslaught of disruptions in recent years have rocked global supply chains. As a result, today’s pharmaceutical industry leaders are seeking to digitalize and streamline supply chains to boost visibility, improve collaboration and connectivity with trading partners, and significantly increase responsiveness and agility. TraceLink is the answer.

End-to-End Supply Network Orchestration

TraceLink is the pharmaceutical and life sciences industry’s leading provider of supply chain digitalization through end-to-end product orchestration on the TraceLink Opus Digital Network Platform—the world’s largest supply chain network digitalization platform. With more than 290,000 network member organizations, TraceLink Opus connects people, processes, systems, and enterprises into a collective information network for intelligent business execution.

TraceLink solutions empower pharmaceutical manufacturers, wholesale distributors, third-party logistics providers, and health system and retail pharmacies to seamlessly and 100% interoperably exchange information with direct and indirect trade partners across the end-to-end supply chain. Purpose built for the pharmaceutical industry to enable real-time supply chain visibility and collaboration and ensure global compliance with track-and-trace requirements, TraceLink solutions deliver business value for customers across four key pillars:

Network: TraceLink customers can exchange business information with all partners through a single link to the TraceLink network, without maintaining separate point-to-point integrations. Each customer and partner can send and receive business information in their preferred format. With the TraceLink network and multienterprise solutions, your organization can “Integrate Once, Interoperate with Everyone .”

Scalability: The TraceLink platform architecture utilizes modern cloud technologies running on Amazon Web Services to process billions of transactions daily. A highly scalable solution eliminates operational disruptions due to data processing and ensures compliance, increases customer satisfaction, and minimizes patient safety impacts.

Continuous Compliance: TraceLink works with customers, partners, regulatory agencies, and government system providers to understand new and emerging requirements so we can continuously scope, develop, test, and deploy new functionality across our network. We maintain the platform and partner integrations simultaneously in a highly controlled manner that is compliant with GxP and related regulations.

Ensure Supply: TraceLink provides global 24x7 support and services. Our platform uses an active-active architecture that provides zero recovery time and no data loss in the event that a hosting zone is affected. Our network data model also creates highly actionable, clean datasets representing the drug supply chain, ensuring full supply chain visibility and driving high impact solutions.

Improve Supply Chain Visibility and Collaboration with MINT!

Demand and supply fluctuations and disruptions at all points along the supply chain are significantly impacting company revenue, working capital, service levels, and profitability. To combat these challenges, supply chain organizations of pharmaceutical manufacturers need end-to-end visibility into product and material status. The newest TraceLink solution—Multienterprise Information Network Tower (MINT)—is purpose built to deliver the end-to-end visibility and powerful real-time collaboration capabilities organizations need to address these challenges. Key capabilities include:

  • MINT leverages a proven model for trade partner identification, authentication, onboarding, and integration, which provides the foundation for developing a true digital twin for each company, its products, and its partners across the end-to-end pharmaceutical supply chain.
  • MINT powers the digital exchange of POs, Invoices, ASNs, and scores of other digital business transactions that businesses and their trade partners rely upon.
  • MINT makes it painless for trade partners to interoperate with any supplier or customer, through a single integration to the TraceLink network, making it a “win-win” for both parties in the business relationship, a key ingredient for true end-to-end visibility.
  • MINT connects to any business system, regardless of version or information exchange protocol, and is designed to meet the needs of a range of partners of any size and digital capability, including those with low digital maturity through an interoperable portal.

With MINT, pharmaceutical supply chain stakeholders gain real-time visibility, collaboration, and the capability to rapidly respond to supply and demand fluctuations and disruptions.

About the TraceLink Network

MINT is just one example of how the TraceLink Opus network and digital solutions enable pharmaceutical industry stakeholders to digitalize supply chains, achieve operational excellence, access to medicine, and ultimately improve patient care. TraceLink also delivers solutions to enable real-time, workflow-driven multienterprise supply chain work management, digital recalls, drug shortage predictions, and more. Here are some additional TraceLink Opus network metrics:

  • 290K+ authenticated and onboarded TraceLink Opus network members
  • 7,300+ live CMO connections across more than 1300 customers
  • 930+ distribution and logistics customers and partners
  • 919M+ regulatory documents processed and exchanged
  • 41.1+ billion serial numbers commissioned to date
  • 14,937+ live serialization connections
  • $4.7+ billion in customer savings by avoiding point-to-point integrations

With the industry-leading supply chain network digitalization platform, a growing portfolio of powerful multienterprise collaboration solutions, and unmatched pharmaceutical supply chain expertise, TraceLink is well-positioned to become a trusted partner and guide in your journey to end-to-end supply chain digitalization.

Learn More About TraceLink Today

About Pharma Supply Chain and Logistics Innovation Programme 2024

Pharma Supply Chain and Logistics Innovation programme is a promising conference of World BI, focusing on different aspects of supply chain challenges especially during the COVID-19 pandemic. Get to know how supply chain professionals ensure the agility and visibility of the complex supply chains with the technological advancements in the world nowadays. Implement the robust supply chain plans as forecasted and monitoring the distribution network, keeping in mind the last mile delivery and patient centricity.

10th Pharma Supply Chain and Logistics Innovation Programme to be held in Movenpick Hotel Basel, Switzerland on 15-16 May 2024.

11th Pharma Supply Chain and Logistics innovation Programme to be held in San Francisco, California on 22-23 October 2024.

This year Pharma Supply Chain and Logistics Innovation programme will come up with new flavors discussing all the challenges for a disrupted supply chain post covid, supply chain management and supply chain differentiation covering technological advancements. This conference is a blend of discussions featuring end-end supply chain, supply chain optimization, product security & authentication and regulatory compliance.

Speakers & delegates from MSD, GSK, Novo Nordisk, Vifor Pharma, Bayer, Johnson and Johnson, Novartis, Cytvia, Clover Biopharma and many more are looking forward to joining this conference.

Register with us to learn more!